The presence of increased numbers of immunosuppressive CD4+CD25+ regulatory T-cells and exhausted CD8+ T-cells within RCC tumors explains the efficacy of immune checkpoint inhibitors in overcoming immune tolerance of the tumor [73, 74]. The gene discussed is CD4; the disease is neoplasm.